Pharmacologic treatments of dementia

This publication has 71 references indexed in Scilit:

• A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease
  Neurology, 2001
• Galantamine in AD
  Neurology, 2000
• The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1
  Dementia and Geriatric Cognitive Disorders, 1999
• Donepezil Improves Cognition and Global Function in Alzheimer DiseaseA 15-Week, Double-blind, Placebo-Controlled Study
  Archives of internal medicine (1960), 1998
• Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
  Published by American Medical Association (AMA) ,1997
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
  Neurology, 1996
• A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group
  Published by American Medical Association (AMA) ,1994
• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group
  JAMA, 1992
• A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's Disease
  New England Journal of Medicine, 1992
• Estimated Prevalence of Alzheimer's Disease in the United States
  The Milbank Quarterly, 1990